Dr. Blay on the Heterogeneity of Soft Tissue Sarcoma

Jean-Yves Blay, MD, PhD
Published: Monday, Feb 06, 2017



Jean-Yves Blay, MD, PhD, professor of Medicine at the Université Claude Bernard, Lyon, France, and the scientific director of the Canceropole Lyon Rhône Alpes, discusses the heterogeneity of soft tissue sarcoma.

There are more than 80 different histological subtypes of sarcomas, and they have not all yet been explored, Blay explains. This will be a major part of research in the field going forward. Additionally, sarcoma remains to be a be a very difficult-to-treat patient population because it is not a homogenous group of tumors.

Clinical presentation, molecular behavior, and histology are all very different from one another in each of these sarcoma subtypes. These subgroups are also very rare, he adds.


Jean-Yves Blay, MD, PhD, professor of Medicine at the Université Claude Bernard, Lyon, France, and the scientific director of the Canceropole Lyon Rhône Alpes, discusses the heterogeneity of soft tissue sarcoma.

There are more than 80 different histological subtypes of sarcomas, and they have not all yet been explored, Blay explains. This will be a major part of research in the field going forward. Additionally, sarcoma remains to be a be a very difficult-to-treat patient population because it is not a homogenous group of tumors.

Clinical presentation, molecular behavior, and histology are all very different from one another in each of these sarcoma subtypes. These subgroups are also very rare, he adds.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x